Peng Zhan

526 total citations
9 papers, 419 citations indexed

About

Peng Zhan is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Peng Zhan has authored 9 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Peng Zhan's work include Click Chemistry and Applications (6 papers), Histone Deacetylase Inhibitors Research (5 papers) and Protein Degradation and Inhibitors (4 papers). Peng Zhan is often cited by papers focused on Click Chemistry and Applications (6 papers), Histone Deacetylase Inhibitors Research (5 papers) and Protein Degradation and Inhibitors (4 papers). Peng Zhan collaborates with scholars based in China, Japan and Jordan. Peng Zhan's co-authors include Xinyong Liu, Takayoshi Suzuki, Xiao Ding, Yukihiro Itoh, Yosuke Ota, Takashi Okamoto, Hidehiko Nakagawa, Naoki Miyata, Kaori Asamitsu and Waleed A. Zalloum and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Peng Zhan

9 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Zhan China 8 240 161 83 56 49 9 419
Federica Orvieto Italy 11 227 0.9× 155 1.0× 129 1.6× 92 1.6× 79 1.6× 17 440
Teodora Pene Dumitrescu United States 11 318 1.3× 55 0.3× 88 1.1× 61 1.1× 46 0.9× 20 522
Christopher C. Lai United States 13 165 0.7× 105 0.7× 84 1.0× 59 1.1× 68 1.4× 24 432
Domenico Tarantino Italy 13 267 1.1× 202 1.3× 135 1.6× 84 1.5× 60 1.2× 21 624
Jadd R. Shelton United States 9 281 1.2× 163 1.0× 166 2.0× 33 0.6× 59 1.2× 13 521
Jintong Du China 9 251 1.0× 100 0.6× 43 0.5× 27 0.5× 85 1.7× 17 385
Maria Tardugno Italy 9 384 1.6× 96 0.6× 48 0.6× 43 0.8× 68 1.4× 10 582
Francesca Morreale Italy 12 448 1.9× 112 0.7× 135 1.6× 96 1.7× 130 2.7× 15 610
Susmith Mukund United States 11 736 3.1× 154 1.0× 236 2.8× 200 3.6× 148 3.0× 13 1.0k
Guannan Geng China 12 437 1.8× 90 0.6× 50 0.6× 43 0.8× 29 0.6× 18 629

Countries citing papers authored by Peng Zhan

Since Specialization
Citations

This map shows the geographic impact of Peng Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Zhan more than expected).

Fields of papers citing papers by Peng Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Zhan. The network helps show where Peng Zhan may publish in the future.

Co-authorship network of co-authors of Peng Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Zhan. A scholar is included among the top collaborators of Peng Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Zhan. Peng Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gong, Qijie, Jian Song, Yihui Song, et al.. (2024). New techniques and strategies in drug discovery (2020–2024 update). Chinese Chemical Letters. 36(3). 110456–110456. 4 indexed citations
2.
Itoh, Yukihiro, Peng Zhan, T Tojo, et al.. (2023). Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation. Journal of Medicinal Chemistry. 66(22). 15171–15188. 12 indexed citations
3.
Meng, Dandan, Wei He, Yan Zhang, et al.. (2021). Development of PI3K inhibitors: Advances in clinical trials and new strategies (Review). Pharmacological Research. 173. 105900–105900. 54 indexed citations
4.
Sun, Lin, Alexej Dick, Megan E. Meuser, et al.. (2020). Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities. European Journal of Medicinal Chemistry. 190. 112085–112085. 92 indexed citations
5.
Du, Jintong, Jing Guo, Dongwei Kang, et al.. (2020). New techniques and strategies in drug discovery. Chinese Chemical Letters. 31(7). 1695–1708. 93 indexed citations
6.
Ju, Han, Siyu Xiu, Xiao Ding, et al.. (2019). Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity. European Journal of Medicinal Chemistry. 187. 111940–111940. 30 indexed citations
7.
Ohya, Susumu, Noriyuki Hatano, Hiroaki Kito, et al.. (2016). Downregulation of the Ca2+‐activated K+ channel KCa3.1 by histone deacetylase inhibition in human breast cancer cells. Pharmacology Research & Perspectives. 4(2). e00228–e00228. 17 indexed citations
8.
Muraki, Katsuhiko, Noriyuki Hatano, Masanori Fujii, et al.. (2014). Downregulation of Ca2+-Activated Cl− Channel TMEM16A by the Inhibition of Histone Deacetylase in TMEM16A-Expressing Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 351(3). 510–518. 37 indexed citations
9.
Suzuki, Takayoshi, Yukihiro Itoh, Yosuke Ota, et al.. (2013). Identification of Highly Selective and Potent Histone Deacetylase 3 Inhibitors Using Click Chemistry-Based Combinatorial Fragment Assembly. PLoS ONE. 8(7). e68669–e68669. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026